This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Basara N, Fauser AA . Safety profile of mycophenolate mofetil Bone Marrow Transplant 2000 26: 1362–1363
Busca A, Saroglia EM, Lanino E et al. Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation Bone Marrow Transplant 2000 25: 1067–1071
Basara N, Blau WI, Romer E et al. Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients Bone Marrow Transplant 1998 22: 61–65
Mookerjee B, Altomonte V, Vogelsang G . Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus Bone Marrow Transplant 1999 24: 517–520
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Busca, A., Locatelli, F. & Falda, M. Safety profile of mycophenolate mofetil: a response. Bone Marrow Transplant 27, 892 (2001). https://doi.org/10.1038/sj.bmt.1703018
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703018
This article is cited by
-
Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)
Bone Marrow Transplantation (2002)